Intended for healthcare professionals

News

Routinely offer MenB jabs to prevent gonorrhoea, UK vaccine committee recommends

BMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2696 (Published 15 November 2023) Cite this as: BMJ 2023;383:p2696
  1. Elisabeth Mahase
  1. The BMJ

The Joint Committee on Vaccination and Immunisation (JCVI) has advised the UK government that meningococcal B (MenB) vaccines should be routinely offered to prevent gonorrhoea by targeting the people at greatest risk.1

Evidence indicates that, even with a modest vaccine effectiveness against gonorrhoea of 32.7-42.0%, rolling out the 4CMenB vaccine to groups with the highest risk could prevent many cases, said the committee. Because infection with the Neisseria gonorrhoeae bacterium does not protect against future infection, many people are commonly reinfected.

Andrew Pollard, JCVI chair, said that …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription